NFKB2 and nasopharyngeal carcinoma: NFKB2 was frequently overexpressed in EBV+ NPC cells, instead of EBV- tumor cells, NPE cells, stromal cells, and immune cells in the TME (Fig. 7g), and has been previously shown to promote tumor growth and survival71.